MustGrow Biologics Corp. (OTCMKTS:MGROF – Get Free Report) saw a large decrease in short interest in August. As of August 31st, there was short interest totaling 2,500 shares, a decrease of 88.5% from the August 15th total of 21,660 shares. Based on an average daily volume of 4,404 shares, the short-interest ratio is currently 0.6 days.
MustGrow Biologics Price Performance
Shares of MGROF stock traded up C$0.02 on Thursday, hitting C$0.32. 6,100 shares of the company’s stock traded hands, compared to its average volume of 5,444. The company’s fifty day simple moving average is C$0.29 and its 200 day simple moving average is C$0.35. MustGrow Biologics has a one year low of C$0.22 and a one year high of C$0.68.
MustGrow Biologics Company Profile
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets.
Further Reading
- Five stocks we like better than MustGrow Biologics
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for MustGrow Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MustGrow Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
